Kynos Therapeutics

Edinburgh, United Kingdom

Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.

$8.5M raised

Apr 2022

Seed

Biotechnology Health Care Medical Therapeutics

Top Investors

IP Group Epidarex Capital Innovate UK Scottish Enterprise

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kynos Therapeutics

How much funding has Kynos Therapeutics raised?

Kynos Therapeutics has raised $8.5M in total funding. The most recent round was Seed. The last funding was announced in April 2022.

Who are Kynos Therapeutics's investors?

Kynos Therapeutics's investors include IP Group, Epidarex Capital, Innovate UK, Scottish Enterprise.

Where is Kynos Therapeutics headquartered?

Kynos Therapeutics is headquartered in Edinburgh, United Kingdom.

What does Kynos Therapeutics do?

Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.

What stage is Kynos Therapeutics at?

Kynos Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 7, 2022.

MLA

"Kynos Therapeutics — Funding & Investors." VCBacked, April 7, 2022, https://www.vcbacked.co/company/kynos-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Kynos Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/kynos-therapeutics

Wikipedia (cite web)

{{cite web |title=Kynos Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kynos-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 7, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K